Based on an innovative nanotechnology approach, Abionic has developed a medical diagnostic device providing fast and low-cost allergy tests.
Abionic will change the game in allergy diagnosis by delivering with its first product, a novel, versatile in-vitro solution to provide instant quantitative diagnosis for allergies. Abionic is ISO 13485 certified. The company employs 8 highly qualified employees, has a strong board of directors and advisory board, and completed a Series A of EUR 1.6m with institutional investors. Abionic has received 14 awards from prestigious organisations.